BioHealth News Archive

After major venture round, Rockville’s RegenxBio Inc. files for IPO – Washington Business Journal

After major venture round, Rockville’s RegenxBio Inc. files for IPO – Washington Business Journal

Mere months after a major venture capital fundraise, Rockville-based biotech RegenxBio Inc. says it's ready to go public. UPCOMING EVENTS AUGUST 18, 2015 ,…

Read More
WuXi AppTec: Investor Relations – Press Releases

WuXi AppTec: Investor Relations – Press Releases

WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical…

Read More
Madison’s Healthtech Cluster: The Rise of Epic and Everybody Else | Xconomy

Madison’s Healthtech Cluster: The Rise of Epic and Everybody Else | Xconomy

Healthcare, agriculture, and manufacturing remain the bread and butter of the private sector in Madison, WI, and the surrounding region, but healthcare IT has…

Read More
World’s first malaria vaccine approved after 30 years of trials | The Times

World’s first malaria vaccine approved after 30 years of trials | The Times

Scientists throughout are celebrating the scoop that the arena’s first vaccine towards malaria has been authorized by way of the . The vaccine, named…

Read More
MedImmune acquires Inovio HPV cancer treatment for $700 million

MedImmune acquires Inovio HPV cancer treatment for $700 million

Inovio Pharmaceuticals has begun collaboration and sold the exclusive rights to an HPV types 16 and 18 vaccine to MedImmune, the biologics research and…

Read More
Can the Maryland region become a top biotech hub by 2023? – Baltimore Sun

Can the Maryland region become a top biotech hub by 2023? – Baltimore Sun

The Maryland region is one of the richest sources of health care knowledge and research innovation in the world. Here you can find more…

Read More
Bill Gates Bets on Biotech’s “Next Big Thing” — The Motley Fool

Bill Gates Bets on Biotech’s “Next Big Thing” — The Motley Fool

It turns out that bacteria could hold a key to transforming how doctors treat disease -- at least that's what Editas, a privately held…

Read More
Rockville-based MacroGenics begins expansion in immunotherapy following $141 million fundraising round – Washington Business Journal

Rockville-based MacroGenics begins expansion in immunotherapy following $141 million fundraising round – Washington Business Journal

Biotech MacroGenics Inc. is growing its footprint, recently leasing 122,000 square feet of wet lab space in the J. Craig Venter Institute in Rockville.…

Read More
Here’s how to make a winning pitch to AOL co-founder Steve Case during his Rise of the Rest bus tour – Baltimore Business Journal

Here’s how to make a winning pitch to AOL co-founder Steve Case during his Rise of the Rest bus tour – Baltimore Business Journal

Entrepreneurs who want to pitch their business plan to Steve Case when his Rise of the Rest venture tour comes to Baltimore next month…

Read More
BioMark Diagnostics Unveils U.S. Strategy

BioMark Diagnostics Unveils U.S. Strategy

BioMark Diagnostics Inc. ("BioMark" or the "Company") (CSE:BUX) (FSE:20B), a leader in next-generation diagnostics using metabolites, announces its strategy to expand operations into the…

Read More
Aeras Announces New CEO and Leadership Structure – Aeras

Aeras Announces New CEO and Leadership Structure – Aeras

Aeras announced today a new leadership structure for the nonprofit biotech organization with Jacqueline E. Shea, Ph.D., the current Chief Operating Officer (COO), assuming…

Read More
Biotech Company Is Developing Transplantable Pig Organs For Humans – Popular Science

Biotech Company Is Developing Transplantable Pig Organs For Humans – Popular Science

Every year, around 8,000 people die waiting for an organ transplant. There just doesn't seem to be enough human organs available for those who…

Read More
Emergent BioSolutions Receives $44 Million CDC Contract to Further Advance Vaccinia Immune Globulin Intravenous Program – MarketWatch

Emergent BioSolutions Receives $44 Million CDC Contract to Further Advance Vaccinia Immune Globulin Intravenous Program – MarketWatch

Emergent BioSolutions Inc. EBS, -1.75% today announced that the Centers for Disease Control and Prevention (CDC) has exercised options under contract 200-2012-52242 for the…

Read More
Roche buys ‘superbug’ diagnostics firm for up to $425 million – Reuters

Roche buys ‘superbug’ diagnostics firm for up to $425 million – Reuters

Roche (ROG.VX) is buying U.S. diagnostics firm GeneWEAVE BioSciences for up to $425 million, expanding the Swiss group's commitment to fighting so-called "superbugs" as…

Read More
“Innovating through the U.S. EDA” – T2 Speakers Series – Sept 9, 2015

“Innovating through the U.S. EDA” – T2 Speakers Series – Sept 9, 2015

TOPIC: "Innovating through the U.S. Economic Development Administration"   PRESENTER:  Julie Lenzer Kirk, Director Office of Innovation and Entrepreneurship U.S. Economic Development Administration   …

Read More